Literature DB >> 5080035

The metabolic pathways of L-3-O-methyldopa.

G Bartholini, I Kuruma, A Pletscher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5080035

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  4 in total

1.  Demethylation of L-3-methoxytyrosine in vivo.

Authors:  G Bartholini; A Pletscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

2.  Plasma concentrations of L-dopa and 3-methoxydopa and improvement in clinical ratings and motor performance in patients with Parkinsonism treated with L-dopa alone or in combination with amantadine.

Authors:  J B Pilling; J Baker; L L Iversen; S D Iversen; T Robbins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-02       Impact factor: 10.154

3.  Effects of 3-O-methyl on L-dopa-facilitated synthesis and efflux of dopamine from rat striatal slices.

Authors:  W Y Chang; R A Webster
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

4.  Catechol-O-methyltransferase inhibition by U-0521 increases striatal utilization of levodopa.

Authors:  A Reches; D Jiang; S Fahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-07       Impact factor: 3.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.